Purpose In multiple sclerosis (MS), the use of preference-based measures is limited to generic measures such as Health Utilities Index Mark 2 and 3, the EQ-5D and the SF-6D. However, the challenge of ...
B cells influence the pathogenesis of multiple sclerosis. Ocrelizumab is a humanized monoclonal antibody that selectively depletes CD20+ B cells. The annualized relapse rate was lower with ocrelizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback